Clinical Trial Update: Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4% [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the safety and efficacy of Drop 0.4% for dry eye disease, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Drop 0.4% (0.4% ophthalmic solution)

Snippet

Sponsor: Avizor SA | Conditions: Eye Dryness | Phase 3 | Status: NOT_YET_RECRUITING